We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCAR icon
851
PACCAR
PCAR
$69.6B
$8.15M 0.01%
214,040
-26,052
-11% -$1.04M
VRSK icon
852
Verisk Analytics
VRSK
$23.7B
$8.15M 0.01%
74,756
-4,151
-5% -$485K
CET
853
Central Securities Corp
CET
$1.65B
$8.14M 0.01%
327,900
+76,523
+30% +$2.04M
DNI
854
DELISTED
Dividend and Income Fund
DNI
$8.11M 0.01%
851,182
-136,174
-14% -$1.48M
NTRS icon
855
Northern Trust
NTRS
$34.3B
$8.1M 0.01%
96,869
-21,700
-18% -$2.03M
HII icon
856
Huntington Ingalls Industries
HII
$13.2B
$8.1M 0.01%
42,541
-448
-1% -$97.5K
TSN icon
857
Tyson Foods
TSN
$20.3B
$8.08M 0.01%
151,233
+33,785
+29% +$1.99M
GDV icon
858
Gabelli Dividend & Income Trust
GDV
$2.67B
$8.07M 0.01%
441,029
+32,116
+8% +$665K
LOGM
859
DELISTED
LogMein, Inc.
LOGM
$8.03M 0.01%
98,428
+13,406
+16% +$1.13M
LTPZ icon
860
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$742M
$8.02M 0.01%
128,584
-6,388
-5% -$397K
PAYC icon
861
Paycom
PAYC
$9.55B
$8.02M 0.01%
65,480
+14,603
+29% +$1.87M
NRG icon
862
NRG Energy
NRG
$25.1B
$8.01M 0.01%
202,189
+96,292
+91% +$3.68M
RHI icon
863
Robert Half
RHI
$4.33B
$7.96M 0.01%
139,146
+366
+0.3% +$22.5K
CXO
864
DELISTED
CONCHO RESOURCES INC.
CXO
$7.94M 0.01%
77,212
-44,434
-37% -$5.89M
PWV icon
865
Invesco Large Cap Value ETF
PWV
$1.77B
$7.92M 0.01%
242,663
+6,549
+3% +$231K
ZBRA icon
866
Zebra Technologies
ZBRA
$17.9B
$7.9M 0.01%
49,602
+5,361
+12% +$893K
FG
867
DELISTED
FGL Holdings Ordinary Shares
FG
$7.89M 0.01%
1,184,430
+781,449
+194% +$6.07M
GSY icon
868
Invesco Ultra Short Duration ETF
GSY
$3.88B
$7.85M 0.01%
156,765
+24,191
+18% +$1.21M
ALV icon
869
Autoliv
ALV
$8.95B
$7.82M 0.01%
111,377
+10,269
+10% +$834K
RGLD icon
870
Royal Gold
RGLD
$19.7B
$7.8M 0.01%
91,027
-944
-1% -$72.7K
USRT icon
871
iShares Core US REIT ETF
USRT
$4.57B
$7.79M 0.01%
173,671
+78,398
+82% +$3.71M
TEVA icon
872
Teva Pharmaceuticals
TEVA
$41.1B
$7.72M 0.01%
500,833
-114,205
-19% -$2.34M
ITRI icon
873
Itron
ITRI
$4.53B
$7.68M 0.01%
162,310
-83,124
-34% -$4.39M
VGK icon
874
Vanguard FTSE Europe ETF
VGK
$31.1B
$7.67M 0.01%
157,821
+19,702
+14% +$1.02M
HYD icon
875
VanEck High Yield Muni ETF
HYD
$4.4B
$7.67M 0.01%
125,607
-39,457
-24% -$2.4M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.